Enacting critical community development through anti-gentrification policy advocacy
Community Development Journal · 28.04.2022 · 57 (2) · 213-233
DOI: 10.1093/cdj/bsaa049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Community Development Journal, online erschienen am 29.10.2020. Verfasst von Claire Bolton. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Following Newman and Goetz’s call for ‘a critical turn in community development practice and research’ and Fursova’s call for ‘community development as a critical practice aimed at advancing the commons’, this paper argues for a critical community development praxis around gentrification that emphasizes anti-displacement policy. It is more important than ever to look beyond market-friendly strategies and the site of the neighbourhood to shape municipal policy in favour of the ‘right to stay put’. As city governments begin to take the loss of affordable housing in urban centers more seriously, community developers can use vital, localized knowledge to strengthen legislative outcomes. I use a case study of a faith-based community development conference circuit to highlight and analyse the limitations of market-based community development and the promising possibilities of anti-displacement policy advocacy.
Förderung
- National Science Foundation
Zitieren
APA
Bolton, C. (2022). Enacting critical community development through anti-gentrification policy advocacy. Community Development Journal, 57(2), 213-233. https://doi.org/10.1093/cdj/bsaa049
Vancouver
Bolton C. Enacting critical community development through anti-gentrification policy advocacy. Community Development Journal. 2022;57(2):213-233. doi:10.1093/cdj/bsaa049
BibTeX
@article{Bolton2022,
author = {Bolton, Claire},
title = {Enacting critical community development through anti-gentrification policy advocacy},
journal = {Community Development Journal},
year = {2022},
volume = {57},
number = {2},
pages = {213--233},
doi = {10.1093/cdj/bsaa049}
}
EUVIMED